Skip to main content
. 2021 Jun 15;183(1):154–169. doi: 10.1093/toxsci/kfab075

Figure 4.

Figure 4.

Increased sensitivity of TiparpH532A mice to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-induced hepatotoxicity and lethality. A, Kaplan-Meier survival curves for Tiparp+/+ treated with 100 µg/kg, and TiparpH532A mice treated with a single injection of 10 (in blue) or 100 µg/kg (in red) TCDD (n =4–6). B, % body weight relative to pretreatment (C) liver somatic index, (D) serum alanine aminotransferase activity, (E) thymus somatic index, and (F) epididymal white adipose tissue somatic index at the days (d) indicated (n =4–6). *p <.05 2-way analysis of variance (ANOVA) followed by Sidak’s post hoc test compared with genotyped-matched control-treated mice. #p <.05 2-way ANOVA followed by Sidak’s post hoc test compared with time-matched TCDD-treated Tiparp+/+ mice. Figure depicts the mean ± SEM.